← Back to Search

Virus Therapy

VAX014 for Bladder Cancer

Phase 1
Waitlist Available
Research Sponsored by Vaxiion Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 28 days
Awards & highlights

Study Summary

This trial is testing a new cancer treatment, called VAX014, to see if it is safe and effective for patients with low-grade bladder cancer.

Eligible Conditions
  • Bladder Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Treatment-Emergence Adverse Events (Safety and Tolerability)
Maximum tolerated dose (MTD) of VAX014
Secondary outcome measures
Anti-Drug Antibodies (Immunogenicity)
Area Under Curve (AUC)
Clearance (Cl)
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: VAX014Experimental Treatment1 Intervention
Intravesical VAX014 (dose: 3.33x10^10 - 9.0x10^11 recombinant bacterial minicells (rBMCs)), given once per week for Weeks 1-6
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VAX014
2019
Completed Phase 1
~10

Find a Location

Who is running the clinical trial?

Vaxiion TherapeuticsLead Sponsor
1 Previous Clinical Trials
32 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer
2019. "A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03854721.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top